

Edith Heard, director of London’s Francis Crick Institute, explains genetics and epigenetics—especially X chromosome inactivation, dosage compensation, and how 3D genome organization regulates gene switching. She discusses her childhood, language barriers, and career path from cancer gene amplification to X-inactivation research, including her discovery of topologically associating domains (TADs) using chromosome conformation capture (3C). She also reflects on leadership roles at EMBL and the Collège de France, and argues for “discovery science” and global, boundary-crossing research.
Edith Heard (scientist; epigenetics/cellular memory chair at Collège de France; CNRS gold medal; studied X-inactivation; founded lab at Institut Curie). Also mentioned: Frances Haugen (Facebook whistleblower) and hosts Thomas Germain and Jess Maddox.
X inactivation is dynamic (brief reactivation early on) and some genes escape; TADs form “balls of wool” interaction blocks that constrain regulatory neighborhoods; exist (X inactive specific transcript) RNA helps silence an entire X chromosome.
EXIST gene coating and silencing; four-cell/8-cell stage reactivation; TADs spanning hundreds of thousands of base pairs; 3C capturing long-range genome interactions.
Written by AI. May contain mistakes.
A discussion on genetics and the significance of epigenetics in heredity.
“She spent her career studying the mechanisms that make us who we are and transforming our understanding of how X chromosomes are expressed.”
Edith shares experiences from her noisy childhood and language development.
“Now, Edith, we're going to be talking genetics today.”
Edith reflects on her challenges in school due to language barriers.
“few years of my life but the Greek side were over communicative almost and so I would tend to focus on two things, music and reading.”
Discussion on Edith's academic journey and her shift from physics to genetics.
“And there I think my father had a big influence.”
Edith describes her early research focus on gene amplification in cancer.
“Well, it was the beginning of an understanding that cancer is about cells that go wrong, and in particular, genetic processes, DNA mutations, DNA rearrangements, deletions.”
Edith discusses her move to Paris and her research on X chromosome inactivation.
“First of all, how did you find life in Paris?”
Exploration of the process of X chromosome inactivation and its dynamics.
“So rather a magical, wonderful molecule.”
Learn about the discovery of TADs and their significance in gene regulation.
“We realise that, in fact, it's much more dynamic.”
Understand the unique educational approach of the Collège de France and its impact.
“We decided to still remain focused on the X chromosome and trying to understand why is it that some genes can reactivate and also what actually is the mechanism of gene silencing during X inactivation.”
Explore Edith's transition to leading EMBL and her vision for European science.
“as a youngster, which presumably you'd overcome by this point but you'd spent your career until now in a lab doing research.”
Discover the vision behind the Francis Crick Institute and its scientific impact.
“But equally, this was, of course, about the time that the Covid pandemic hit.”
Learn about the endless opportunities in fundamental science and advice for future researchers.
“The Crick is truly an amazing institute.”

Get the gist, explore an idea or ask about something said.
On Discovery, what are the key points of this episode?
Automatic transcript. May contain errors.
0:00This BBC podcast is supported by ads outside the UK.
0:30Syrup. Spice up fall at Whole Foods Market. Part of why I blew the whistle was I didn't want to lay in bed in 20 years. Having seen another million people die, I know that I could have done something when I had a chance. This week on The Interface, we're talking to Frances Haugen. The Facebook whistleblower who leaked the documents that changed how the world saw social media. And now she is the subject of Aaron Sorkin's latest movie, The Social Reckoning. So join me, Thomas Germain. And me, Jess Maddox, for The Interface. Listen on BBC.com or wherever you get your podcasts.
1:27She spent her career studying the mechanisms that make us who we are and transforming our understanding of how X chromosomes are expressed. Today, Edith is director of London's Francis Crick Institute and holds the chair of epigenetics and cellular memory at the Collège de France in Paris. Her career has taken her to the cutting edge of European science and earned her honours including France's highest scientific distinction, the CNRS gold medal. Not bad for someone who describes her younger self as a shy, introverted child who would hide under the sofa with a book to avoid the noisy household goings-on.
2:06Maybe it comes down to good genes. Edith Hurd, welcome to Life Scientific. Thank you. Very happy to be here. Now, Edith, we're going to be talking genetics today. Can you just give us a quick reminder of what we're going to be talking about and also where epigenetics comes in. Genetics is an understanding of heredity. Where do our characteristics come from? Discovery that actually chromosomes transmit this information and that chromosomes are made up in part of DNA. Epigenetics is something that has ranged from understanding what the impact of the environment is on our genes and our bodies right through to understanding how specific genes can be switched on or off and then kept off throughout life.
2:50Right. And then sometimes that goes wrong in diseases like cancer. I mentioned, Edith, in the introduction that you grew up in a fairly raucous household. Tell me about your parents and that busy, noisy childhood home of yours in London. Well, my father wasn't noisy at all. He was quite quiet. He was English and an engineer who loved building things, everything from signaling networks for British Rail that he was working for, right through to building small engines in the garage. My mother was Greek and in fact had come to London to train as an anaesthetist nurse, so very interested in medicine.
3:32And she was very much an extrovert, someone who was extremely generous and kind. And I was brought up in the late 60s, early 70s, And it was a time of political distress, I would say. In Greece, there was a military junta. So we had many people from our family who were political exiles, who came over to stay with us to keep out of danger. And within my immediate family, I had people who were royalists, people who were communists. We had very passionate discussions in the house. and so it was quite, I would say, agitated. I'm not sure if raucous is the word but agitated. But I also alluded to the fact that as a child you found this, let's call it boisterous environment, quite challenging.
4:21How did you deal with it? Well, first of all, I had to manage the language issue so I could only speak Greek for the first few years of my life but the Greek side were over communicative almost and so I would tend to focus on two things, music and reading. So I'd play the piano obsessively and I would read books and I would literally hide under the sofa when the Greek debates about politics became a bit too passionate. And then I would follow my father down to his garage where he would show me how he would build engines. So it was a strange childhood. You mentioned you only spoke Greek. I mean, OK, your mother's Greek, so she'd have taught you her language, but your father's English and you're living in London.
5:06How come you weren't bilingual? It's very strange, but that was a period of... It only lasted apparently a couple of years, but where doctors were telling parents of different nationalities or cultures that a child should only learn one language at a time. That now sounds ridiculous because children can absorb almost as many languages as you throw at them. But they were told, well, Greek is clearly going to be the second language eventually, so you should start with Greek, only speak to her in Greek, which meant that even my father, who couldn't speak Greek, had to learn Greek in order to communicate with me.
5:39And did that make life difficult for you once you started primary school? Oh, it was very traumatic. I remember the first day of primary school where literally I walked in and I couldn't understand what they were saying to me. And luckily, I had a little friend who was also Greek, but her parents had actually spoken to her in English as well. And so she would translate for me. So yes, I think it was a bit of a baptism of fire, but it really taught me how to be open to listening carefully, watching, understanding what's going on in a room. And it lasted for a few years, actually. I only became fluent English speaking after about two or three years.
6:17But when it came to secondary school, you found your stride. Yeah, and primary school, I struggled. And so when I started secondary school, I thought, OK, this is a fresh start. And it was really a new era for me. And I had become increasingly interested in maths, but eventually I became specialised in science. And there I think my father had a big influence. Well, you did take A-levels in maths, further maths, physics and chemistry. You got a place at the University of Cambridge to read natural sciences. That's where you spend the first year studying a range of science subjects before specialising.
6:54You went there thinking you'd focus on physics and astronomy. me. But in fact, you ended up being drawn to genetics. It happened quite surprisingly. In my first year, I really did think I would end up becoming an astronomer. Realised quite rapidly that this was a challenge. First year physics, it was quite tough. And I wasn't sure I was going to manage three years of this. So I took on biology as my fourth topic, which I'd never done before at school. I felt totally out of my depth, but I fell in love with it. And one morning, I just woke up and I had this moment of this is what I want to do. And I chose genetics because as someone who was doing maths, I thought, well, this was the simplest part of biology to actually get into.
7:36Well, Edith Hurd, you graduated in 1986 with a first class degree and moved back to London to start your doctoral research at the Imperial Cancer Research Fund Laboratories, which is now Cancer Research UK. And here you were focusing on gene amplification in cancer cells. What did that involve? Well, it was the beginning of an understanding that cancer is about cells that go wrong, and in particular, genetic processes, DNA mutations, DNA rearrangements, deletions. So the lab that I joined was interested in understanding how certain regions contain genes that needed to be more highly expressed in order to push the cancer process.
8:21And one of these processes was this gene amplification. These were before the days of high throughput sequencing of genomes. I spent four years working hard at trying to understand how this very big and complicated piece of DNA had come to be. I realised that in order to understand how things go wrong, it's actually important to understand how things work properly in the first place. So I made the conscious decision that my next step would be to work on a process that was, if one wants to call it normal or physiological. Well, this influenced your next step, as did your French partner and future husband, Vincent, who'd been studying in the UK, but was moving back home.
9:06So in 1990, you moved to Paris to take up a postdoctoral research role at the Pasteur Institute. First of all, how did you find life in Paris? Paris was very different I'd spent the first 25 years of my life in London other than the few years I spent at university I had to adapt it it was difficult for the first couple of years I couldn't speak the language so I was dropped in at the deep end I also had my first child my daughter a year and a half after arriving and you know I was changing so much in my life at the same time it did take a while to adapt but I realized also that it's those sorts of changes that make you step up and reinvent certain aspects of what you do.
9:48Absolutely, absolutely. Well, on the work front, you'd become interested in a genetic process involving X chromosomes called dosage compensation. Yes, I decided to work on a process that happens during the early part of life when the embryo is developing. It's a process known as X chromosome inactivation, whereby one of the two X chromosomes in females is shut down in order to compensate for the double dose of X chromosomes in females versus males where there's only one X. There's one X chromosome and one Y. So to deal with that imbalance in evolution, different strategies have come about. In mammals in particular, the strategy is this process of X chromosome inactivation.
10:32It was discovered by Mary Lyon, a British geneticist, many decades ago. And when I arrived in the lab of Phil Avner at the Pasteur Institute, we really didn't know very much other than that one of the two X chromosomes is shut down. My project was to understand how do you switch off a whole chromosome. I was lucky enough that when I arrived, one gene had just been discovered. And I had to try and understand how this one gene that had been stumbled upon worked in order to switch off a whole chromosome. And this gene, this is the EXIST gene? Yeah, it stands for X inactive specific transcript. It's a non-coding RNA.
11:08So it's an unusual gene in that it doesn't end up producing a protein, it just produces an RNA. And the RNA that it produces only comes from one of the two X chromosomes and will coat that chromosome almost entirely and switch it off. So rather a magical, wonderful molecule. So how was it that you went about studying this gene then? I used the approaches that I'd learned during my PhD, which were to try and analyse big chunks of DNA. So I would clone very big pieces of DNA from the X chromosome that contained this gene. And to just ask, is a big piece of DNA with this gene sufficient if I put it somewhere else in the genome to switch off a chromosome?
11:51And for the first few years, I would do this experiment with bigger and bigger pieces of DNA. And even the biggest piece of DNA with exist would not be sufficient. We knew that this gene exist was actually necessary because if you deleted it or took it away, the chromosome couldn't get switched off. And yet, if you just took it as a single copy and put it somewhere else, it wasn't working. So it was a bit of an enigma. And it got me thinking what is missing in my very large bits of DNA that means that this gene doesn't work when I put it into a different part of the genome. And I think, you know, just to make sure we haven't lost listeners, we're talking about DNA, the double helix, long strands of molecules.
12:32And the particular gene is a whole sequence. It's not a single molecule, right? It's a whole sequence of these bases on the site. So you're looking along the whole DNA, trying to find the regions that influence this particular gene. That's right. We know that genes, particularly in organisms like mammals, have to have nearby sequences, other bits of DNA, to make sure they get switched on and off in the right place at the right time. So my quest was to understand what are the missing bits of DNA that will allow exist to be switched on only when there are two X chromosomes in a cell, and only on one of the two X chromosomes.
13:11That was the initial question, which sounds very simple, but actually it's a very, very fundamental question that is useful in understanding how the rest of the genome works as well. What are the sequences that allow a gene to be switched on or switched off at a given time. And once that decision is made, how do you then maintain that decision? Keep it switched off, yeah. Well, in 2001, you set up your own laboratory at the Curie Institute, named, of course, after its founder, Marie Curie. Within a few years there, you did have your breakthrough in understanding X inactivation. And it turned out that this process was much more nuanced than previously realised.
13:51The prevailing view was that once X inactivation is set up during development, that state of inactivity of 1X chromosome is stably maintained throughout life. We realise that, in fact, it's much more dynamic. 1X chromosome gets silenced in the very first stages of life, four cell stage, eight cell stage, and then it gets reactivated briefly, and then subsequently becomes inactivated again. And then, although it's fairly stably inactive, there's increasing evidence that, in fact, many genes on the X chromosome are not quite as silent as we imagine, they can come back on. That means you have a double dose of some genes in a female compared to a male.
14:31And that was much more heterogeneous and dynamic than people had thought. Well, we come now, Edith, to what was a huge discovery, something you named topologically associating domains or TADS, T-A-D. Now, before we dig into what they are and how they work. Tell me about the research that led you there. The original question that I had was, what does it take to switch off one of the two X chromosomes? What are the missing sequences around the exist gene that would allow it to work? We realised that in order to capture what was missing, we needed to apply a technique that would identify these missing sequences.
15:10I heard a scientist called Job Decker, who's in the States, who gave a talk about a new technique he developed called chromosome confirmation capture. This is back in the early 2000s. And I managed to convince a brilliant student I had called Elfej Nora that maybe this would allow us to identify the missing sequences. So this 3C technique allows you to capture all the interactions of the genome in cells as they happen. And if a gene needs to be switched on and off by a particular sequence, you would expect to catch it in the act. And this would be a way of capturing these sometimes very distant sequences that were involved.
15:48And how are you doing the capture? What are you seeing? So you take cells and what we say is fix them. So you catch these interactions in the act and you don't let them separate in time. You fix them chemically. Then you can take that fixed DNA and using techniques that will allow you to either amplify or sequence those bits of DNA, you can find out what are the junctions. Was one part of the genome interacting with another part of the genome and how frequently? And of course, the bits of the genome that are next to each other on a chromosome are the most frequent interactions. We were looking for the longer range interactions that were perhaps less frequent, but would be those missing elements I'd been looking for.
16:31But when we did the experiment, we kept seeing not these single interactions with our favourite gene exists, we would see these blocks of interacting regions that looked, if one can make the analogy, like balls of wool. Where the wool string here is the DNA. Yeah, the string is the DNA. And there were some regions that seemed to just interact much more frequently with each other than with their immediate neighbours. So it was like balls of wool, tads along the bit of the chromosome that we were looking at. And we suddenly realised the exist gene was in between two of these TADs, which were very large, several hundreds of thousands of base pairs long, and that probably the exist gene needed both of these in order to be regulated properly.
17:13So it was a very large, what we call regulatory landscape that we had picked up. But it turns out, and at the same time there was another lab doing similar approaches genome-wide, it turns out that this principle of TADs could be found across the whole genome. This is the way the genome is organised, and it actually could be a helpful way of making sure that a gene is in the right neighbourhood and is being influenced in the right way by its neighbourhood rather than being randomly influenced by anything that happens to come its way. So you coined this term, topologically associating domains, to describe these balls of wool DNA that are influencing this gene and to explain the folding of the DNA strands that allowed these neighbourhoods to trigger the gene.
17:58So where did this discovery take you next in terms of your lab work? We decided to still remain focused on the X chromosome and trying to understand why is it that some genes can reactivate and also what actually is the mechanism of gene silencing during X inactivation. It's all fine to say we've discovered TADS and we know how the genome folds perhaps, but that still doesn't give us the molecular mechanism. I was sort of going to ask, you talk about switching a gene on and off, but also it's on with the whole of the X chromosome being inactivated due to some small section of DNA that exists gene.
18:36It is rather magical that a single gene exists is able to produce the silencing of a whole chromosome pretty much. So something that my lab and others are now actively working on, how do you actually switch a gene off when this RNA hits the chromosome? What does it bring with it? What are the weapons that will lead to silencing? And how do some genes actually escape for this, avoid this entirely and stay on or even come back on? Incredible. Well, Edith, in 2012, alongside running the lab, you took on the role of professor and chair of epigenetics and cellular memory at the Collège de France, which some listeners may know is a rather unique educational institution.
19:20For anyone who hasn't come across it, can you just explain the setup and what it does? Yeah, the Collège of France was set up by François Premier, a very enlightened king of France back in 1530, who wanted to make sure that the French public would have access to education, I guess, independently of the church. so he set up this college of professors each professor is a specialist in a particular area and the idea was that each professor would be teaching research as it happens so very topical science or art or history that is being researched that would then be communicated to the public it's open to the public anyone can come in off the street to listen to the lectures none of the professorships, none of the chairs are perpetual.
20:09In other words, when a professor retires or dies, the chair is not continued. A new chair is elected on a topic that is of current interest. It's an amazing institution because it really does provide for the transmission of information to everyone in every part of society. So when I give my lectures, I have students coming in, people coming in off the street. I once had a taxi driver who dropped me off and asked me what I was and I told him, well, I'm going to give my lecture and he actually, can I come? Absolutely. You have teachers who come in, you have a lot of people who are retired. So these lectures happen every year.
20:47They have to be different every year and they have to be delivered in a sufficiently clear way that the general public can grasp them and yet that you capture the imagination of scientists who come in who are specialists in the area as well. We talked earlier about you being quite shy and introverted as a youngster, which presumably you'd overcome by this point but you'd spent your career until now in a lab doing research. Were you daunted by the idea of addressing an actual audience giving lectures? Absolutely especially as it had to be in French and even though I managed to pick up French this was a whole different level of communication in French that I wasn't necessarily that comfortable with.
21:29But I decided to do it because I realised that lecturing on my topic would be a wonderful opportunity for me to dive into the science that was happening and become familiar with it. And very quickly, I realised that there was something immensely satisfying in being able to communicate science to the public and feel that this was something that really was appreciated and useful. So despite my shyness, which I still have, it's still challenging for me to stand up and speak. I really did start to appreciate how important it was to communicate. Well, this obviously helped further your reputation. And in 2019, you accepted the role of Director General of the prestigious European Molecular Biology Laboratory, known as EMBL or EMBL.
22:20I know you were enjoying your lab work. So did you have any qualms about taking on this new and my different role? I kind of realised that maybe it would be useful for someone like me, a scientist who had had a very active and successful career, to take on a bigger role in an organisation that was designed to try and help support European science as a whole. And so when I started at EMBL, I was asked to come up with a whole new program accelerating into research areas that no other institute alone could do. EMBL being funded by 27 at the time now, 30 member states, it needed to do something that was ahead of the game.
23:09So we came up with a program that was called Molecules to Ecosystems that touched on topics as far apart as planetary biology, human ecosystems, microbial ecosystems, theory. And this was really important for the funders, our member states, to think, well, actually, this is the future for European science. So we got a very substantial increase in funding and we attracted people from disciplines that normally would not have thought of coming to the molecular biology organisation that EMBL is. So it was an exciting time. And I felt that I kind of owed it to the community to give back in this way.
23:50So lots of positives then. But equally, this was, of course, about the time that the Covid pandemic hit. So it was also a period of massive upheaval. Yes, it was very, very challenging from a human point of view, from a scientific point of view. But also, this was a crisis where scientists were relevant. You know, in order to get through a pandemic, we needed science. And at Ambel, you know, we needed to continue delivering. And it was really interesting to see how a scientific organisation can rapidly step up when needed for such a crisis. This is why you need scientific institutions to exist.
24:31Well, Liliath, last year, having built your whole career abroad, you returned to London to take on the directorship of the renowned biomedical research centre, the Francis Crick Institute. Yes, it was an unexpected decision. I was not planning necessarily to take on a new directorship. But then this offer came along. And in fact, I realised that all that I love about science and the way it's done is kind of represented by the Crick. The Crick is truly an amazing institute. It's one building that houses everything from the, you know, the research scientists right through to clinicians, to industrial partners, facilities, everything under one room, and set up really with the vision of doing discovery science that can have huge impacts on human health, and doing it swiftly and without boundaries.
25:27And that was very attractive. So I said yes. So you mentioned the importance of discovery science. What would you say are the big opportunities for fundamental science today? I think they're never ending, because one imagines that, you know, the blue sky research that has been done has led to enough discoveries that actually we can just get on now and find how to, you know, solve the problems that need to be solved. But actually, there's so much that we don't know. And my time at EMIL and my time at the College of France has led me to think about things like biodiversity. And we still need to explore all of the unmapped organisms on this planet.
26:07And by so doing, we're not just going to create an encyclopedia, we're actually going to discover new things, how things work. You know, it's thanks to understanding how the DNA molecule was structured way back when, you know, Francis Crick, Jim Watson, Rosalind Franklin. Thanks to that discovery that we now understand so much about genomes and how the genome is used and how a body is constructed thanks to the DNA variations that it has in it. So I think that discovery science and allowing that to happen without predicting necessarily what its applications will be is really important to defend and to support.
26:49So bearing all that in mind, are there any words of advice you'd offer to the next generation of researchers at this time of such swift change? My advice would be, be bold, be curious, be brave. At times like this, where, you know, the world is in turmoil, it's important to remember that science is successful when people move around, that science should happen without boundaries, that in a way the scientific endeavour is a global endeavour, and crossing both, I would say, geographic boundaries, but also scientific boundaries is key to success. Edith Head, thank you very much for sharing your life, Scientific.
27:32Thank you. Part of why I blew the whistle was I didn't want to lay in bed in 20 years, having seen another million people die, and know that I could have done something when I had a chance. This week on The Interface, we're talking to Frances Haugen. The Facebook whistleblower who leaked the documents that changed how the world saw social media. And now she is the subject of Aaron Sorkin's latest movie, The Social Reckoning. So join me, Thomas Germain. And me, Jess Maddox, for The Interface. Listen on BBC.com or wherever you get your podcasts.
Imagine looking at a map of a city you thought you knew inside-out, only to discover a collection of tightly knit neighbourhoods that nobody had ever realised existed... Edith Heard has achieved something rather similar with DNA.
Edith is a leading expert in epigenetics: put simply, the science around how our bodies can turn particular genes on or off without actually altering our DNA. She’s spent her career studying the mechanisms that make us who we are and transforming our understanding of how X chromosomes are expressed; notably, how female cells turn off the spare X chromosome.
Talking to Professor Jim Al-Khalili, Edith discusses her journey from a shy and introverted youngster to the cutting edge of European science - including her latest role as Director of London’s prestigious Francis Crick Institute.